Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Off label use, Pyrexia, Rash erythematous, Vaccination site rash
Clinical narrative: 102 fever for 2 days; Extremely swollen lymph nodes-the size of a large orange on the side of neck / swollen lymph nodes in arm pit; red rash near injection site; red rash near injection site; fatigue; general unwell feeling; Dose 1: Moderna ; Dose 2: Moderna ; Dose 3: COVID 19, brand=Pfizer; Dose 1: Moderna ; Dose 2: Moderna; Dose number: 3; product: COVID 19, brand: Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 10:30 (Lot number: FG3527) at the age of 49 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Heart murmur" (unspecified if ongoing); "COVID" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: DIVIGEL; PROGESTERONE; NP THYROID; NEOMYCIN. Vaccination history included: Moderna (Dose: 2, brand: Moderna, Batch/Lot No: 046A21A, Location of injection: Arm Left, Time: 09:00 AM; Epstein Barr virus 2 months prior most recent vaccine   ), administration date: 20Mar2021, when the patient was 48 years old, for Covid-19 immunization, reaction(s): "Epstein Barr virus"; Moderna (Dose: 1, brand: Moderna, Batch/Lot No: 030M20A, Location of injection: Arm Left, Time: 08:00 AM), administration date: 20Feb2021, when the patient was 48 years old, for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious) with onset 02Dec2021 10:30, outcome "unknown", described as "Dose 1: Moderna ; Dose 2: Moderna ; Dose 3: COVID 19, brand=Pfizer"; INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 02Dec2021 10:30, outcome "unknown", described as "Dose 1: Moderna ; Dose 2: Moderna"; IMMUNISATION (non-serious) with onset 02Dec2021 10:30, outcome "unknown", described as "Dose number: 3; product: COVID 19, brand: Pfizer"; PYREXIA (non-serious) with onset 02Dec2021 19:00, outcome "recovered", described as "102 fever for 2 days"; LYMPHADENOPATHY (non-serious) with onset 02Dec2021 19:00, outcome "not recovered", described as "Extremely swollen lymph nodes-the size of a large orange on the side of neck / swollen lymph nodes in arm pit"; RASH ERYTHEMATOUS (non-serious), VACCINATION SITE RASH (non-serious) all with onset 02Dec2021 19:00, outcome "recovering" and all described as "red rash near injection site"; FATIGUE (non-serious) with onset 02Dec2021 19:00, outcome "recovering", described as "fatigue"; MALAISE (non-serious) with onset 02Dec2021 19:00, outcome "recovering", described as "general unwell feeling". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of off label use, interchange of vaccine products, pyrexia, lymphadenopathy, rash erythematous, vaccination site rash, fatigue, malaise.  Additional information: Patient did not receive any other vaccine in four weeks. Prior to vaccination, patient was diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. Relevant medical history and concurrent conditions: Heart murmur and Epstein Barr virus 2 months prior most recent vaccine. Reported Event: 102 fever for 2 days, extremely swollen lymph nodes-the size of a large orange on the side of neck- still there 4 days later, swollen lymph nodes in arm pit, red rash near injection site, fatigue, general unwell feeling. Events did not result in prolonged Hospitalization Prolonged. Patient has not received any treatment for the events.   Follow-up attempts are completed. No further information is expected.